Abstract:
Sudarshana powder (SP) is an Ayurvedic preparation, which contains 53 herbal ingredients along with 50% of Andrographis paniculata
and is clinically used with bees honey. +is study was aimed to determine the safety pro4le of the SP, and its novel preparation
Sudarshana suspension (SS) on male Wistar rats and tolerance studies were conducted for healthy adult volunteers. Acute and subacute
toxicity studies of the SS and hot water extract of SP were assessed in Wistar rats by observing the general behavior, analyzing
biochemical and haematological parameters, and pathological observation. Healthy consented adult volunteers (n � 35) of either sex
were selected, and tolerance studies of SS were tested by measuring the biochemical and haematological parameters. +ere were no
signi4cant (p>0.05) changes observed in the treated animals with SS and hot water extract of SP compared with control in body
weights, food intake, and water consumption as well as the biochemical and haematological parameters. Histopathological studies
revealed no signi4cant (p>0.05) changes in the liver, heart, and kidney tissues. +e experimental results suggest that novel formulation
SS was potentially safe for chronic administration in rats, and no signi4cant di8erences (p>0.05) were observed in tested parameters on
day 3 and day 8 when compared to the day 0 (baseline) values in healthy volunteers. Healthy volunteers did not report any adverse e8ects
or any other complications during the treatment period and the follow-up period. +erefore, it can be concluded that the novel
preparation Sudarshana suspension does not cause any signi4cant toxic e8ects on the blood parameters in animal and human models.
